Boundless Bio, Inc. (BOLD) Plans to Raise $101 Million in March 28th IPO
Boundless Bio, Inc. (BOLD) expects to raise $101 million in an initial public offering (IPO) on Thursday, March 28th, IPO Scoop reports. The company will issue 6,300,000 shares at $15.00-$17.00 per share. The company has a market cap of $355.8 million. Goldman Sachs, Leerink Partners, Piper Sandler and Guggenheim Securities acted as the underwriters for […]
More Stories
Independent Bank Group (NASDAQ:IBTX) Earns Sell Rating from Analysts at StockNews.com
StockNews.com assumed coverage on shares of Independent Bank Group (NASDAQ:IBTX – Free Report) in a research note published on Wednesday...
Tonix Pharmaceuticals (NASDAQ:TNXP) Research Coverage Started at StockNews.com
StockNews.com initiated coverage on shares of Tonix Pharmaceuticals (NASDAQ:TNXP – Free Report) in a research note published on Wednesday. The...
Builders FirstSource (NYSE:BLDR) Upgraded at StockNews.com
StockNews.com upgraded shares of Builders FirstSource (NYSE:BLDR – Free Report) from a hold rating to a buy rating in a...
Alphabet (NASDAQ:GOOGL) Stock Rating Lowered by JMP Securities
Alphabet (NASDAQ:GOOGL – Get Free Report) was downgraded by investment analysts at JMP Securities from an “outperform” rating to a...
Athersys (NASDAQ:ATHX) Earns Hold Rating from Analysts at StockNews.com
StockNews.com assumed coverage on shares of Athersys (NASDAQ:ATHX – Free Report) in a research note issued to investors on Wednesday....
Cantor Fitzgerald Reaffirms Overweight Rating for Celldex Therapeutics (NASDAQ:CLDX)
Celldex Therapeutics (NASDAQ:CLDX – Get Free Report)‘s stock had its “overweight” rating restated by stock analysts at Cantor Fitzgerald in...